This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Montefiore Medical Center. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Chemotherapy: The Contributions of Richard Lopachin
Introduction
Richard Lopachin is an accomplished inventor based in New York, NY. He has made significant contributions to the field of medicine, particularly in the treatment of chemotherapy-induced side effects. His work focuses on developing methods to mitigate the adverse effects of chemotherapeutic agents.
Latest Patents
Lopachin holds a patent for "Nucleophilic chemicals useful in the treatment of cisplatin-induced sensory neuropathy and ototoxicity." This patent discloses methods and compositions aimed at reducing neuropathy or ototoxicity associated with chemotherapeutic agents. The innovative approach involves administering one or more enol compounds to a subject, providing a potential breakthrough in patient care.
Career Highlights
Richard Lopachin is affiliated with Montefiore Medical Center, where he applies his expertise in medical research and innovation. His dedication to improving patient outcomes through scientific advancements is evident in his work and contributions to the medical community.
Collaborations
Lopachin collaborates with Brian C Geohegan, further enhancing the research and development efforts in their field. Their partnership exemplifies the importance of teamwork in driving innovation and improving therapeutic strategies.
Conclusion
Richard Lopachin's contributions to the field of chemotherapy treatment highlight the importance of innovation in medicine. His patent and ongoing work at Montefiore Medical Center demonstrate a commitment to enhancing patient care and addressing the challenges posed by chemotherapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
